Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China

Journal of Antibiotics

Volumn 67, Issue 12, 2014, Pages 799-805

  Wang, Yanchun ^a   Zhao, Shengyuan ^b   Han, Lizhong ^b   Guo, Xiaokui ^a   Chen, Min ^c   Ni, Yuxing ^b   Zhang, Yan ^a   Cui, Zelin ^a   He, Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c Shanghai Municipal Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 1; BETA LACTAMASE CTX M 9; CEFACLOR; CEFAZOLIN; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL DNA; BETA LACTAMASE;

AFABC GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; UROPATHOGENIC ESCHERICHIA COLI; AGED; CHEMISTRY; CHI SQUARE DISTRIBUTION; CLUSTER ANALYSIS; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETICS; INCIDENCE; MALE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; URINARY TRACT INFECTIONS; VIRULENCE;

ESCHERICHIA COLI;

AGED; BETA-LACTAMASES; CHI-SQUARE DISTRIBUTION; CHINA; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHYLOGENY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84925284739     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2014.72     Document Type: Article

References (33)

1. Sussman,M.Molecular Medical Microbiology (Academic Press, New York, NY, 2002).
2. Dolejska,M. et al. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents. J. Antimicrob. Chemother. 66, 2784-2790 (2011).
3. Nicolas-Chanoine, M. H. et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61, 273-281 (2008).
4. Peirano, G. & Pitout, J. D. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: The worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35, 316-321 (2010).
5. Bashir, S., Haque, A., Sarwar, Y., Ali, A. & Anwar, I. Virulence profile of different phylogenetic groups of locally isolated community acquired uropathogenic E. coli from Faisalabad region of Pakistan. Ann. Clin. Microbiol. Antimicrob. 11, 23 (2012).
6. Johnson, J. R. & Stell, A. L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181, 261-272 (2000).
7. Johnson, J. R. & Russo, T. A Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int. J. Med. Microbiol. 295, 383-404 (2005).
8. Picard, B. et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67, 546-553 (1999).
9. Tabibian, J. H. et al. Uropathogens and host characteristics. J. Clin. Microbiol. 46, 3980-3986 (2008).
10. R.Murray, P. Manual of Clinical Microbiology (American Society for Microbiology, Washington, DC, 2007).
11. Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing Eighteenth Informational Supplement M100-S18 edn. (Institute CaLS, Wayne, PA, USA, 2008).
12. Clermont, O., Bonacorsi, S. & Bingen, E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66, 4555-4558 (2000).
13. Herschleb, J., Ananiev, G. & Schwartz, D. C. Pulsed-field gel electrophoresis. Nat. Protoc. 2, 677-684 (2007).
14. Ribot, E. M. et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathogen. Dis. 3, 59-67 (2006).
15. Bush, K. & Jacoby, G. A. Updated functional classification of beta-lactamases. Antimicrob. Agents Chemother. 54, 969-976 (2010).
16. Bush, K., Jacoby, G. A. & Medeiros, A. A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39, 1211-1233 (1995).
17. Akinci, E. & Vahaboglu, H. Minor extended-spectrum beta-lactamases. Expert Rev. Anti Infect. Ther. 8, 1251-1258 (2010).
18. Kurt, G. et al. Urogenital Infections (Grafos, Spain, 2010).
19. Naber, K. G., Schito, G., Botto, H., Palou, J. & Mazzei, T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for empiric therapy. Eur. Urol. 54, 1164-1175 (2008).
20. Wagenlehner, F. M., Wullt, B. & Perletti, G. Antimicrobials in urogenital infections. Int. J. Antimicrob. Agents 38 (suppl: 3-10) (2011).
21. Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing Twentieth Informational Supplement M100-S20 edn (Institute CaLS, Wayne, PA, USA, 2010).
22. Cao, X. et al. Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in Chinese hospitals. J. Clin. Microbiol. 49, 2496-2501 (2011).
23. Fennell, J. et al. Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: An observational study. BMC Infect. Dis. 12, 116 (2012).
24. Park, S. H. et al. Molecular epidemiology of extended-spectrum beta-lactamaseproducing Escherichia coli in the community and hospital in Korea: Emergence of ST131 producing CTX-M-15. BMC Infect. Dis. 12, 149 (2012).
25. Liu, W. et al. Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J. Antimicrob. Chemother. 63, 895-900 (2009).
26. Abdallah, K. S., Cao, Y. & Wei, D. J. Epidemiologic Investigation of Extraintestinal pathogenic E. coli (ExPEC) based on PCR phylogenetic group and fimH single nucleotide polymorphisms (SNPs) in China. Int. J. Mol. Epidemiol. Genet. 2, 339-353 (2011).
27. Grude, N. et al. A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection. Clin. Microbiol. Infect. 13, 208-211 (2007).
28. Moreno, E. et al. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J. Antimicrob. Chemother. 57, 204-211 (2006).
29. Johnson, J. R. et al. Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis. Infect. Immun. 59, 2311-2315 (1991).
30. Johnson, J. R., Van der Schee, C., Kuskowski, M. A., Goessens, W. & Van Belkum, A. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J. Infect. Dis. 186, 1852-1856 (2002).
31. Soto, S. M. et al. Biofilm formation in uropathogenic Escherichia coli strains: Relationship with prostatitis, urovirulence factors and antimicrobial resistance. J. Urol. 177, 365-368 (2007).
32. Ejrnaes, K. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan. Med. Bull. 58, B4187 (2011).
33. Karisik, E., Ellington, M. J., Livermore, D. M. & Woodford, N. Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum beta-lactamases in the UK. J. Antimicrob. Chemother. 61, 54-58 (2008).